Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An aggressive malignant smooth muscle neoplasm, arising from the central nervous system. It is characterized by a proliferation of neoplastic spindle cells.
No clinical trials have been registered for central nervous system leiomyosarcoma.
5 publications have been identified in PubMed for central nervous system leiomyosarcoma. Research spans Case Report / Case Series (60%) and Basic Science / Preclinical (40%).
Vaillant J (2026). [PMID: 41756758](https://pubmed.ncbi.nlm.nih.gov/41756758/). *Neuro-oncology advances*. [Basic Science / Preclinical]
Berkowitz NE (2026). [PMID: 41993565](https://pubmed.ncbi.nlm.nih.gov/41993565/). *bioRxiv*. [Basic Science / Preclinical]
Weber MD (2024). [PMID: 39250829](https://pubmed.ncbi.nlm.nih.gov/39250829/). *Journal of neurosurgery. Case lessons*. [Case Report / Case Series]
Koruga N (2024). [PMID: 38741997](https://pubmed.ncbi.nlm.nih.gov/38741997/). *Surgical neurology international*. [Case Report / Case Series]
Nath J (2024). [PMID: 39239451](https://pubmed.ncbi.nlm.nih.gov/39239451/). *Indian journal of surgical oncology*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 18, 2026, 3:59 AM UTC